PSA on PRS: Population Genomic Screens Need More Than Pathogenic Variants

Public health is greatly benefiting from population genomics screening, as it provides patients with risk education and treatment for symptoms of life-threatening diseases that they would not have been aware of through routine checkups. So, why hasn't population genomic screening realized its full potential? As an internist geneticist and Medical Affairs Director at Helix, this issue became all the more real for Cassie Hajek, MD, when she was diagnosed with breast cancer that evaded existing genetic testing procedures. In this earnest episode, Hajek shares how her experiences as both a cancer patient and a practitioner have helped her identify and build towards overcoming some of the barriers to maximizing population genomic screening for preventive medicine.

Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.

Produced by Bill Levine

Hosted by Jonathan D. Grinstein

Audio mixed and mastered by Jason Mack

Music provided by Artem Hramushkin

Hosted on Acast. See acast.com/privacy for more information.